Abstracts tagged "systemic lupus erythematosus (SLE) and renal disease"

Abstract Number: 651 • 2019 ACR/ARP Annual Meeting
Predictors of Renal Damage in Systemic Lupus Erythematosus Patients from Latin America
Cristina Reátegui-Sokolova¹, Manuel Ugarte-Gil ², Guillermina B Harvey ³, Guillermo Pons-Estel ⁴, Rosana Quintana ⁵, Luis Catoggio ⁶, Enrique Soriano ⁷, Mercedes Garcia ⁸, Veronica Saurit ⁹, Francisco Caeiro ¹⁰, Eloisa Bonfa ¹¹, Nílzio da Silva ¹², Emilia Sato ¹³, Gloria Vasquez ¹⁴, Loreto Massardo ¹⁵, Oscar Neira ¹⁶, Mario Cardiel ¹⁷, Ignacio Garcia De-La Torre ¹⁸, Mary-Carmen Amigo ¹⁹, Marlene Guibert-Toledano ²⁰, Margarita Portela-Hernandez ²¹, Rosa Chacon-Diaz ²², Graciela Alarcón ²³ and Bernardo A. Pons-Estel ²⁴, ¹Hospital Guillermo Almenara Irigoyen. EsSalud, Lima, Peru, ²Universidad Científica del Sur, Lima, Peru, ³GLADEL, Rosario, Argentina, ⁴Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina, ⁵Centro Regional de Enfermedades Autoinmunes y Reumáticas (CREAR), Grupo Oroño,Rosario, Rosario, Argentina, ⁶Rheumatology Section, Internal Medicine Service, Hospital Italiano de Buenos Aires, Argentina., Ciudad Autonoma de Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina, ⁷Rheumatology Section, Internal Medicine Service, Hospital Italiano de Buenos Aires, Argentina., Buenos Aires, Buenos Aires, Argentina, ⁸Hospital San Martín, La Plata, Argentina, ⁹Hospital Privado, Centro Médico de Córdoba, Córdoba, Argentina, Cordoba, Argentina, ¹⁰Hospital Privado de Córdoba, Cordoba, Argentina, ¹¹Rheumatology Division, Hospital das Clinicas, Faculdade de Medicina da Universidade de Sao Paulo (HCFMUSP), Sao Paulo, Brazil., Sao Paulo, Sao Paulo, Brazil, ¹²Universidade Federal de Goiás, Goiânia, Goias, Brazil, ¹³Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil., San Pablo, Brazil, ¹⁴University of Antioquia, Medellin, Antioquia, Colombia, ¹⁵Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia. Universidad San Sebastián, Santiago, Chile., Santiago, Chile, ¹⁶Sección Reumatología, Hospital del Salvador. Universidad de Chile. Unidad de Reumatología. Clínica Alemana de Santiago, Facultad de Medicina Clínica Alemana, Universidad del Desarrollo., Santiago, Chile, Santiago, Chile, ¹⁷Centro de Investigación Clínica de Morelia, SC, Morelia, México., Morelia, Mexico, ¹⁸Departamento de Inmunología y Reumatología,Htal General de Occidente y Universidad de Guadalajara.Mexico, Guadalajara, Mexico, ¹⁹Servicio de Reumatología, Centro Médico ABC, Ciudad de México, México., Mexico, Mexico, ²⁰GLADEL, La Habbana, Cuba, ²¹Departamento de Reumatología, Hospital de Especialidades CMN SXXI, IMSS, Ciudad de México, Mexico, Mexico, ME, ²²Servicio de Reumatología, Policlínica Méndez Gimón, Caracas, Venezuela., Caracas, Venezuela, ²³University of Alabama at Birmingham, Birmingham, ²⁴Centro Regional de Enfermedades Autoinmunes y Reumáticas (CREAR), Grupo Oroño, Rosario, Rosario, Argentina
Background/Purpose: Lupus nephritis and renal damage are serious complications in patients with SLE. Proteinuria < 0.8 g/24 hours at 12 months has proven to be a…
Abstract Number: 1605 • 2019 ACR/ARP Annual Meeting
Homocysteinemia Predicts Renal Insufficiency in Systemic Lupus Erythematosus
Hakan Babaoglu¹, Jessica Li ², Daniel Goldman ³, Laurence Magder ⁴ and Michelle Petri ², ¹Gazi University School of Medicine, Ankara, Turkey, ²Johns Hopkins University School of Medicine, Baltimore, MD, ³Johns Hopkins University School of Medicine, Baltimore, MD, ⁴University of Maryland School of Medicine, Baltimore, MD
Background/Purpose: Homocysteinemia is present 8-15% of patients with SLE and is associated with increased risk of atherosclerosis, arterial thrombosis and stroke in SLE patients. Recently,…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].